Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arkstone is a health technology company specializing in artificial intelligence solutions for infectious disease diagnostics and antimicrobial stewardship. The company's platform translates complex laboratory results into actionable clinical reports, helping healthcare providers select the most effective treatments while combatting antibiotic resistance. Their core technology, the Arkstone Report, integrates with various diagnostic platforms to provide clear, evidence-based guidance for clinicians. By automating the interpretation of molecular and microbiology tests, Arkstone aims to improve patient outcomes and promote responsible antibiotic use across the healthcare continuum.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arkstone.